Pricing

Oric Pharmaceuticals

0 followers

‌

ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more

Industries

Biotechnology, Health Care

Headquarters

South San Francisco, United States

Employees

Links

Org chart

CEO

Jacob Chacko

Collapse

Chief Business Officer

Dominic Piscitelli

Chief Financial Officer

Chief Scientific Officer

Chief Medical Officer

Christian V. Kuhlen

General Counsel

Edna Chow Maneval

Senior Vice President, Clinical Development

Vice President, Head Of People

Executive Director

Board & advisors

Charles Sawyers

Founder

Board Member

Founder & Chairman Scientific Advisory Board

Founder

Board Member

Board Member

Steve L. Hoerter

Board Member

Teams

Scientific Research Team

20 members

Research and Development

11 members

Board and Advisory Team

10 members

Leadership Team

9 members

Finance and Accounting

5 members

Operations Team

5 members

Offices

Similar companies

Neurelis

2 followers

Bill & Melinda Gates Medical Research Institute

4 followers

Pfizer

528 followers

Immunovant

6 followers

REVOLUTION Medicines

5 followers

Stemline Therapeutics

3 followers

AnaptysBio

3 followers

Rigel Pharmaceuticals

3 followers

Atomica

1 follower

Takeda Oncology

15 followers

Arcturus Therapeutics

2 followers

Explore companies